Veritas  
   
 
   
Veritas Health Economics Consulting
 

Find Out How Veritas Can Assist You

 
 

PUBLICATIONS

 

Selected Publications and Abstracts

Merchant S, Noe L, Howe A, Duff SB, Gricar J, Ogden K, Mody S. A budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic pain. ISPOR 17th Annual International Meeting; Washington, DC; June 2012.

-----------------------------

Hughes KE, Duff SB, Husain N, Cooperberg MR.  Leveling the playing field: a case study on technical precision in comparative effectiveness research for clinically localized prostate cancer.  ISPOR 16th Annual International Meeting; Baltimore, MD; May 2011.

-----------------------------

Cooperberg MR, Ramakrishna N, Duff SB, Hughes KE, Sadownik S, Smith JA, Tewari AK. Primary treatments for clinically localized prostate cancer: systematic review and cost-utility analysis.  Annual Meeting of the American Urological Association; Washington, DC; May 2011.

-----------------------------

Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. Journal of Urology 2006;176:1500-1506.

-----------------------------

Jones AL, Ackerman SJ, Knight T, Duff SB. Costs versus reimbursement for treatment of open tibia fracture in a California Medicaid population. Scientific Program of the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), Washington, DC, February 23-27, 2005.

-----------------------------

Mehta J, Duff SB, Gupta S. Cost effectiveness of bortezomib in the treatment of advanced multiple myeloma. Managed Care Interface 2004;17:52-61.

-----------------------------

Reyes C, Hernandez J, Duff SB, Knight T, Calkins H. An economic analysis of catheter ablation for the treatment of ventricular tachycardia. Value in Health 2004;7(6):689.

-----------------------------

Jones AL, Swiontkowski MF, Polly DW, Duff SB, Ackerman SJ. Use of rhBMP-2 in the treatment of open tibial shaft fractures: do improved clinical outcomes outweigh the additional expense of rhBMP-2? Journal of Bone and Joint Surgery 2004 Orthopaedic Trauma Association Annual Meeting.

-----------------------------

Duff SB, Scott EA, Mafilios MS, Todd EC, Krilov LR, Geddes AM, Ackerman SJ. Cost-effectiveness of a targeted disinfection program in household kitchens to prevent foodborne illnesses in the United States, Canada, and the United Kingdom. Journal of Food Protection 2003;66:2103-2115.

-----------------------------

Barron R, Carlsen J, Duff SB, Burk C. Estimating the cost of an emergency room visit for migraine headache. Journal of Medical Economics 2003;6:43-53.

-----------------------------

Duff SB, Mordin MM. Strategies for assessing health economic and quality of life outcomes in multiple sclerosis. Expert Review of Pharmacoeconomics and Outcomes Research 2002;2:577-587.

-----------------------------

Mehta J, Duff S, Gupta S. Bortezomib is cost-effective for the treatment of relapsed and refractory multiple myeloma. Blood 2003;102(11):500a-501a.

-----------------------------

Duff S, Carlsen J, Barron R, Ravelo A, Burk C. Estimating the cost of an emergency room visit for migraine headache. Medical Decision Making 2003;23(6):546.

-----------------------------

Duff SB, Scott EA, Mafilios MS, Todd EC, Krilov LR, Geddes AM, Ackerman SJ. The cost-effectiveness of a targeted disinfection program in household kitchens to prevent foodborne illnesses in the United States, Canada, and the United Kingdom. Journal of Food Protection 2003;66[supplement A]:136.

-----------------------------

Ackerman SJ, Duff SB, Dennehy PH, Mafilios MS, Krilov LR. Economic impact of an infection control education program in a preschool setting. Pediatrics 2001;108:E102.

-----------------------------

Duff SB, Mafilios MS, Ackerman SJ. Economic evaluation of infection control practices in day care and the home: methodologic challenges and proposed solutions. Pediatric Infectious Disease Journal 2000;19:S125-128.

-----------------------------

Calkins H, Bigger Jr. JT, Ackerman SJ, Duff SB, Wilber D, Kerr RA, Bar-Din M, Beusterien K, Strauss MJ. Cost effectiveness of catheter ablation in patients with ventricular tachycardia. Circulation 2000;101:280-288.

-----------------------------

Krilov LR, Duff SB, Mafilios MS, Ackerman SJ. Economic impact of an infection control education program in a preschool setting. Pediatric Research 2000;47:267A.

-----------------------------

Griffiths R, Duff S, Prosek B, Llana T. Simulated lifetime costs to National Health Service (NHS) of biological and mechanical heart valve replacement in younger versus older patients. Value in Health 1999;2:351-352.

-----------------------------

Calkins H, Duff S, Ackerman SJ, Wilber D, Kerr RA, Strauss MJ. Cost-effectiveness of catheter ablation in patients with ventricular tachycardia. Circulation 1999;100:I-374.

-----------------------------

Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, Berenbaum PA, Goldman PA, Williams LW, Weinstein MC. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease. Neurology 1999;52:1138-1145.

Back To Top

 

 
 

Veritas Health Economics Consulting
Home | Services | About Us | Publications | Contact Us
Copyright 2007-2009 | All Rights Reserved
Designed and developed by Knock - Marketing and Design